Nrf2 augments skeletal muscle regeneration after ischaemia-reperfusion injury

Journal of Pathology

Volumn 234, Issue 4, 2014, Pages 538-547

  Al Sawaf, Othman ^a   Fragoulis, Athanassios ^a   Rosen, Christian ^a   Keimes, Nora ^a   Liehn, Elisa Anamaria ^a   Hölzle, Frank ^a   Kan, Yuet Wai ^b   Pufe, Thomas ^a   Sönmez, Tolga Taha ^a   Wruck, Christoph Jan ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ischaemia reperfusion injury; MyoD; Nrf2; Skeletal muscle

Indexed keywords

INTERLEUKIN 6; METHYSTICIN; MYOGENIC FACTOR; MYOGENIN; TRANSCRIPTION FACTOR NRF2; MYOD PROTEIN; NFE2L2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; DOWN REGULATION; HISTOPATHOLOGY; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATORY CELL; ISCHEMIA; LUCIFERASE ASSAY; MACROPHAGE; MOUSE; MUSCLE INJURY; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; REPERFUSION INJURY; SKELETAL MUSCLE; UPREGULATION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; DNA MICROARRAY; GENETIC TRANSFECTION; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; REGENERATION; SKELETAL MUSCLE SATELLITE CELL;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; MYOD PROTEIN; NF-E2-RELATED FACTOR 2; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REGENERATION; REPERFUSION INJURY; SATELLITE CELLS, SKELETAL MUSCLE; TRANSFECTION;

EID: 84910606993     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4418     Document Type: Article

References (34)

1. Wakabayashi N, Slocum SL, Skoko JJ, et al. When NRF2 talks, who's listening? Antioxid Redox Signal 2010; 13: 1649-1663.
2. Wasserman WW, Fahl WE. Functional antioxidant responsive elements. Proc Natl Acad Sci USA 1997; 94: 5361-5366.
3. Itoh K, Wakabayashi N, Katoh Y, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Gene Dev 1999; 13: 76-86.
4. Kweider N, Fragoulis A, Rosen C, et al. Interplay between vascular endothelial growth factor (VEGF) and nuclear factor erythroid 2-related factor-2 (Nrf2): implications for preeclampsia. J Biol Chem 2011; 286: 42863-42872.
5. Wruck CJ, Streetz K, Pavic G, et al. Nrf2 induces interleukin-6 (IL-6) expression via an antioxidant response element within the IL-6 promoter. J Biol Chem 2011; 286: 4493-4499.
6. Wakabayashi N, Shin S, Slocum SL, et al. Regulation of notch1 signaling by nrf2: implications for tissue regeneration. Sci Signal 2010; 3: ra52.
7. Huebner AJ, Dai D, Morasso M, et al. Amniotic fluid activates the nrf2/keap1 pathway to repair an epidermal barrier defect in utero. Dev Cell 2012; 23: 1238-1246.
8. Schafer M, Farwanah H, Willrodt AH, et al. Nrf2 links epidermal barrier function with antioxidant defense. EMBO Mol Med 2012; 4: 364-379.
9. Zhao R, Hou Y, Xue P, et al. Long isoforms of NRF1 contribute to arsenic-induced antioxidant response in human keratinocytes. Environ Health Perspect 2011; 119: 56-62.
10. Charge SB, Rudnicki MA. Cellular and molecular regulation of muscle regeneration. Physiol Rev 2004; 84: 209-238.
11. Aziz A, Liu QC, Dilworth FJ. Regulating a master regulator: establishing tissue-specific gene expression in skeletal muscle. Epigenetics 2010; 5: 691-695.
12. Rudnicki MA, Braun T, Hinuma S, et al. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 1992; 71: 383-390.
13. Chan K, Lu R, Chang JC, et al. NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci USA 1996; 93: 13943-13948.
14. Sönmez TT, Al-Sawaf O, Brandacher G, et al. A novel laser-Doppler flowmetry assisted murine model of acute hindlimb ischemia-reperfusion for free flap research. PLoS One 2013; 8: e66498.
15. Al-Sawaf O, Fragoulis A, Rosen C, et al. Nrf2 protects against TWEAK-mediated skeletal muscle wasting. Sci Rep 2014; 4: 3625.
16. Springer ML, Rando TA, Blau HM. Gene delivery to muscle. In Current Protocols in Human Genetics. Wiley: New York, 2001.
17. Wruck CJ, Gotz ME, Herdegen T, et al. Kavalactones protect neural cells against amyloid β-peptide-induced neurotoxicity via extracellular signal-regulated kinase 1/2-dependent nuclear factor erythroid 2-related factor 2 activation. Mol Pharmacol 2008; 73: 1785-1795.
18. Jahn L, Sadoshima J, Izumo S. Cyclins and cyclin-dependent kinases are differentially regulated during terminal differentiation of C2C12 muscle cells. Exp Cell Res 1994; 212: 297-307.
19. Megeney LA, Kablar B, Garrett K, et al. MyoD is required for myogenic stem cell function in adult skeletal muscle. Gene Dev 1996; 10: 1173-1183.
20. Anderson JE, Wozniak AC. Satellite cell activation on fibers: modeling events in vivo - an invited review. Can J Physiol Pharmacol 2004; 82: 300-310.
21. Zhang C, Li Y, Wu Y, et al. Interleukin-6/signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration. J Biol Chem 2013; 288: 1489-1499.
22. Ardite E, Barbera JA, Roca J, et al. Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-ê B activation. Am J Pathol 2004; 165: 719-728.
23. Hansen JM, Klass M, Harris C, et al. A reducing redox environment promotes C2C12 myogenesis: implications for regeneration in aged muscle. Cell Biol Int 2007; 31: 546-553.
24. Bouzid MA, Hammouda O, Matran R, et al. Changes in oxidative stress markers and biological markers of muscle injury with aging at rest and in response to an exhaustive exercise. PLoS One 2014; 9: e90420.
25. Kombairaju P, Kerr JP, Roche JA, et al. Genetic silencing of Nrf2 enhances X-ROS in dysferlin-deficient muscle. Front Physiol 2014; 5: 57.
26. Ichihara S, Yamada Y, Liu F, et al. Ablation of the transcription factor Nrf2 promotes ischemia-induced neovascularization by enhancing the inflammatory response. Arterioscler Thromb Vasc Biol 2010; 30: 1553-1561.
27. Gutmann E, Schiaffino S, Hanzlikova V. Mechanism of compensatory hypertrophy in skeletal muscle of the rat. Exp Neurol 1971; 31: 451-464.
28. Rudnicki MA, Le Grand F, McKinnell I, et al. The molecular regulation of muscle stem cell function. Cold Spring Harb Symp Quant Biol 2008; 73: 323-331.
29. Forcales SV, Puri PL. Signaling to the chromatin during skeletal myogenesis: novel targets for pharmacological modulation of gene expression. Semin Cell Dev Biol 2005; 16: 596-611.
30. Mal A, Harter ML. MyoD is functionally linked to the silencing of a muscle-specific regulatory gene prior to skeletal myogenesis. Proc Natl Acad Sci USA 2003; 100: 1735-1739.
31. Miller CJ, Gounder SS, Kannan S, et al. Disruption of Nrf2/ARE signaling impairs antioxidant mechanisms and promotes cell degradation pathways in aged skeletal muscle. Biochim Biophys Acta 2012; 1822: 1038-1050.
32. Safdar A, deBeer J, Tarnopolsky MA. Dysfunctional Nrf2-Keap1 redox signaling in skeletal muscle of the sedentary old. Free Radic Biol Med 2010; 49: 1487-1493.
33. Collins CA. Satellite cell self-renewal. Curr Opin Pharmacol 2006; 6: 301-306.
34. Narasimhan M, Hong J, Atieno N, et al. Nrf2 deficiency promotes apoptosis and impairs PAX7/MyoD expression in aging skeletal muscle cells. Free Radic Biol Med 2014; 71: 402-414.